Design, construction, implementation, and cost of a hospital pharmacy cleanroom

American Journal of Health-System Pharmacy

Volumn 55, Issue 5, 1998, Pages 458-463

  Schumock, Glen T ^a,b   Kafka, Patrick S ^b   Tormo, Vicente J ^c  

^a Director of Pharm/Respiratory Care   (United States)

^b Aspirus Wausau Hospital   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Administration; Air; Aseptic areas; Compounding; Contamination; Costs; Injections; Particles; Personnel,pharmacy; Pharmaceutical services; Pharmacy, institutional, hospital; Planning and design; Staff development; Standards; Sterile products; Workload

Indexed keywords

ANTINEOPLASTIC AGENT; MIDAZOLAM;

AIR; AIR CONDITIONING; AIRFLOW; ARTICLE; CLEANING; CONSTRUCTION WORK AND ARCHITECTURAL PHENOMENA; COST; COST BENEFIT ANALYSIS; DRUG SOLUTION; DRUG SYNTHESIS; FILTRATION; HOSPITAL PHARMACY; MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; STAFF TRAINING;

EID: 0032030923     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.5.458     Document Type: Article

References (15)

1. Federal standard 209E. Airborne paniculate cleanliness classes in cleanrooms and clean zones. Washington, DC: General Services Administration; 1992.
2. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on quality assurance of pharmacy-prepared sterile products. Am J Hosp Pharm. 1993; 50:2386-98.
3. ASHP Council on Professional Affairs. Draft guidelines on quality assurance for pharmacy prepared sterile products. Am J Hosp Pharm. 1992; 49:407-17.
4. Sterile drug products for home use. The United States pharmacopeia, 23rd rev., and The national formulary, 18th ed. Rockville, MD: United States Pharmacopeial Convention; 1994:1963-75.
5. Tormo VJ. Perspective on sterile compounding and the draft guidelines. Am J Hosp Pharm. 1992; 49:946-7.
6. Santell JP, Kamalich RF. National survey of quality assurance activities for pharmacy-prepared products in hospitals and home infusion facilities-1995. Am J Health-Syst Pharm. 1996; 53:2591-605.
7. Trissel LA, Chandler SW, Anderson RW. Indoor air is nearly cleanroom quality. Am J Hosp Pharm, 1993; 50:1858, 1861. Letter.
8. Gianino RR. Misconceptions about cleanrooms. Am J Hosp Pharm. 1994; 51:239-40. Letter.
9. Trissel LA, Chandler SW, Anderson RW. Reply. (Misconceptions about cleanrooms.) Am J Hosp Pharm. 1994; 51:240. Letter.
10. Kraft R. Cleanroom-construction concerns. Am J Hosp Pharm. 1994; 51:935. Letter.
11. Samuelson D, Clark T. Pharmacy preparation meets the contamination control challenge. Cleanrooms. 1993; 7(Aug):12-4.
12. Lau D, Shane R, Yen J. Quality assurance for sterile products: simple changes can help. Am J Hosp Pharm. 1994; 51:1353. Letter.
13. Allan EL, Barker KN, Severson RW et al. Design and evalua tion of a sterile compounding facility. Am J Health-Syst Pharm. 1995; 52:1421-7.
14. Wright B. Detailed planning to upgrade the sterile-products preparation area to a cleanroom. Am J Health-Syst Pharm. 1995; 52:1750,1753-5.
15. Occupational Safety and Health Administration. OSHA technical manual (instructional publication CPL 2-2.20B CH-4). Chap. 24. Controlling occupational exposure to hazardous drugs. Washington, DC: U.S. Department of Labor; 1995:21/1-21/32.